Athletic Rebuild's $1.1 Million Seed Funds a HIPAA-Compliant Bet on Virtual Rehab

Founder Tayla Cannon, a physiotherapist with a 130,000-follower Instagram, is building Rebuildr to help other clinicians scale their own online practices.

About Athletic Rebuild

Published

For an athlete, an injury is more than a physical setback. It is a psychological maze of fear, frustration, and a ticking clock to return to form. The standard path to recovery is often a series of in-person physiotherapy appointments, a process that can be geographically limiting, expensive, and difficult to scale. Tayla Cannon, an Australian physiotherapist and former bodybuilder who relocated to Austin, built her first business, Athletic Rebuild, on the premise that expert guidance for this population could be delivered remotely. Now, with a $1.1 million seed check from Slow Ventures, she is betting that the real opportunity lies in building the tools for other clinicians to do the same [Traded, April 2026].

From DTC Programs to a Platform for Clinicians

Athletic Rebuild began as a direct-to-consumer brand, selling 12- and 24-week hybrid training programs for injury recovery and performance on the TrainHeroic marketplace for $150 to $249 [TrainHeroic, retrieved 2024]. The model leveraged Cannon's dual credibility as a clinician and a content creator with over 130,000 Instagram followers [Findarticles.com, retrieved 2026]. But the seed funding is explicitly earmarked for a more ambitious pivot: the launch of Rebuildr, a HIPAA-compliant software platform designed for licensed physical therapists and performance coaches to run their own virtual or hybrid practices [Traded, April 2026].

The move shifts the company's focus from being a service provider to becoming an enablement layer for an entire profession. Rebuildr promises a single platform for client assessments, progress tracking, clinical documentation, and payment processing, all built to meet privacy standards for protected health information [rebuildr.net, retrieved 2026]. Perhaps more critically for adoption, it bundles this software with mentorship from clinicians who have already built six-figure online businesses, addressing the business acumen gap many therapists face [rebuildr.net, retrieved 2026].

Why Slow Ventures Backed a Creator-Clinician

The investment came from Slow Ventures' Creator Fund, a signal that the bet is as much on Cannon's personal brand and audience as it is on the software's technical specs [TechCrunch, November 2025]. For a venture firm, backing a founder with a built-in distribution channel and subject-matter expertise in a regulated field is a compelling combination. Cannon's background stitches together the necessary threads: clinical training as a physiotherapist, hands-on experience training clients, and the demonstrated ability to build an online community [company site, retrieved 2024].

The Competitive Landscape for Virtual Rehab

Competitor Primary Model Key Differentiator
Athletic Rebuild (Rebuildr) B2B Software & Mentorship HIPAA-compliant platform for clinicians to run virtual practices.
Petroski Physio Direct-to-Consumer Telehealth Established brand in online sports physiotherapy.
Athletic Potential PT Direct-to-Consumer Telehealth Focus on strength and conditioning integration.

The Risks in a Regulated Field

The company's ambitions are tempered by the realities of the healthcare market. While the platform's HIPAA-compliant infrastructure is a necessary baseline, it is not a unique moat [Google Play, retrieved 2026]. The more significant hurdles are commercial and behavioral:

  • Sales motion. Selling software to independent healthcare practitioners is notoriously difficult.
  • Market fragmentation. The target customer base of solo or small-group practitioners is fragmented.
  • Platform shift. Convincing a clinician to move their client management, billing, and documentation onto a new, unproven platform requires immense trust.

What to Watch in the Next Twelve Months

The immediate milestone is the successful commercial launch of Rebuildr, which is slated for early 2026 [IMP.NEWS, retrieved 2026]. Traction will be measured not in consumer program sales, but in the number of licensed clinicians who adopt the platform to run their practices. Financially, the $1.1 million seed round provides a runway to build the initial team and product. A logical next step would be a seed extension or Series A round in late 2026 or early 2027, contingent on demonstrating early platform adoption.

Read on Startuply.vc